Therapy of Inflammatory Bowel Disease using 5-Aminosalicylic Acid, 4-Aminosalicylic Acid and Olsalazine Retention Enemas: Review of Clinical Trials
The knowledge that 5-aminosalicylic acid (5-ASA) is the active compound of sulphasalazine and that it acts topically has stimulated the use of 5-ASA containing enemas and ocher similar compounds such as olsalazine and 4-aminosalicylic acid (4-ASA). 5-ASA enemas have been shown to be effective in con...
Saved in:
Main Authors: | M. Campieri, P. Gionchetti, A. Belluzzi, C. Brignola, P. Iannone, M. Miglioli, L. Barbara |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
1989-01-01
|
Series: | Canadian Journal of Gastroenterology |
Online Access: | http://dx.doi.org/10.1155/1989/768562 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Topical Treatment of Ulcerative Colitis using Enemas Containing 5-Aminosalicylic Acid and Beclomethasone Dipropionate
by: M Campieri, et al.
Published: (1990-01-01) -
Efficacy of 5-Aminosalicylic Acid Enemas in the Treatment of Distal Ulcerative Colitis
by: MG Robinson, et al.
Published: (1990-01-01) -
5-Aminosalicylic Acid Enemas in the Maintenance of Remission in Distal Ulcerative Colitis and Proctitis
by: Lloyd R Sutherland, et al.
Published: (1987-01-01) -
Lupus-Like Syndrome Caused by 5-Aminosalicylic Acid in Patients with Inflammatory Bowel Disease
by: Andrew W Kirkpatrick, et al.
Published: (1999-01-01) -
Five-Aminosalicylic Acid: An Update for the Reappraisal of an Old Drug
by: Cristiana Perrotta, et al.
Published: (2015-01-01)